相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evidence-Based Assessment of Genes in Dilated Cardiomyopathy
Elizabeth Jordan et al.
CIRCULATION (2021)
The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies
Nienke M. Stege et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Clinical Impact of Secondary Risk Factors in TTN-Mediated Dilated Cardiomyopathy
John R. Giudicessi et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2021)
Dilated cardiomyopathy caused by truncating titin variants: long-term outcomes, arrhythmias, response to treatment and sex differences
Christoffer Rasmus Vissing et al.
JOURNAL OF MEDICAL GENETICS (2021)
A novel gain-of-function mutation in SCN5A responsible for multifocal ectopic Purkinje-related premature contractions
Nicolas Doisne et al.
HUMAN MUTATION (2020)
Titin Truncating Variants in Adults Without Known Congestive Heart Failure
James P. Pirruccello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Can Circulating Cardiac Biomarkers Be Helpful in the Assessment of LMNA Mutation Carriers?
Przemyslaw Chmielewski et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN Gene
Mohammed Majid Akhtar et al.
CIRCULATION-HEART FAILURE (2020)
Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure
Navin Suthahar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
A combination of quinidine/mexiletine reduces arrhythmia in dilated cardiomyopathy in two patients with R814W SCN5A mutation
Joanna Zakrzewska-Koperska et al.
ESC HEART FAILURE (2020)
Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy
Pablo Garcia-Pavia et al.
CIRCULATION (2019)
Genomics-First Evaluation of Heart Disease Associated With Titin-Truncating Variants
Christopher M. Haggerty et al.
CIRCULATION (2019)
Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
M. Akhtar et al.
CURRENT CARDIOLOGY REPORTS (2019)
Association of Titin-Truncating Genetic Variants With Life-threatening Cardiac Arrhythmias in Patients With Dilated Cardiomyopathy and Implanted Defibrillators
Ben Corden et al.
JAMA NETWORK OPEN (2019)
Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology
Antoine Bondue et al.
CARDIOVASCULAR RESEARCH (2018)
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure An Individual Patient Data Meta-Analysis
Alberto Aimo et al.
CIRCULATION (2018)
Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-termlife-threatening arrhythmias
Job A. J. Verdonschot et al.
EUROPEAN HEART JOURNAL (2018)
Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework
Sean V. Tavtigian et al.
GENETICS IN MEDICINE (2018)
Genetic Etiology for Alcohol-Induced Cardiac Toxicity
James S. Ware et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Clinical Manifestations and Long-Term Mortality in Lamin A/C Mutation Carriers From a Japanese Multicenter Registry
Kenzaburo Nakajima et al.
CIRCULATION JOURNAL (2018)
Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation
Seung Hoan Choi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Severe Course of Peripartum Cardiomyopathy and Subsequent Recovery in a Patient with a Novel TTN Gene-Truncating Mutation
Karolina E. Kryczka et al.
AMERICAN JOURNAL OF CASE REPORTS (2018)
A-Band Titin Truncation in Zebrafish Causes Dilated Cardiomyopathy and Hemodynamic Stress Intolerance
Inken G. Huttner et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy
Joeri A. Jansweijer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Titin-truncating variants affect heart function in disease cohorts and the general population
Sebastian Schafer et al.
NATURE GENETICS (2017)
Truncating Variants in Titin Independently Predict Early Arrhythmias in Patients With Dilated Cardiomyopathy
Upasana Tayal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Phenotype and Clinical Outcomes of Titin Cardiomyopathy
Upasana Tayal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Titin Truncating Variants in Dilated Cardiomyopathy - Prevalence and Genotype-Phenotype Correlations
Maria Franaszczyk et al.
PLOS ONE (2017)
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases
Yigal M. Pinto et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT
Aharon Medina et al.
HEART RHYTHM (2016)
Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers
Saurabh Kumar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies
James S. Ware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Recovery of Cardiac Function in Cardiomyopathy Caused by Titin Truncation
Leanne E. Felkin et al.
JAMA CARDIOLOGY (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease
Angharad M. Roberts et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Does p. Q247X in TRIM63 Cause Human Hypertrophic Cardiomyopathy?
Rafal Ploski et al.
CIRCULATION RESEARCH (2014)
High-Sensitivity Troponin I and Amino-Terminal Pro-B-Type Natriuretic Peptide Predict Heart Failure and Mortality in the General Population
Paul M. McKie et al.
CLINICAL CHEMISTRY (2014)
Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases
Claudio Rapezzi et al.
EUROPEAN HEART JOURNAL (2013)
Variants of the Lamin A/C (LMNA) Gene in Non-Valvular Atrial Fibrillation Patients A Possible Pathogenic Role of the Thr528Met Mutation
Michal Saj et al.
MOLECULAR DIAGNOSIS & THERAPY (2012)
Truncations of Titin Causing Dilated Cardiomyopathy
Daniel S. Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study
Kristen K. Patton et al.
HEART RHYTHM (2011)
Plasma concentrations of N-terminal atrial natriuretic peptide are raised in asymptomatic relatives of dilated cardiomyopathy patients with left ventricular enlargement
J Grzybowski et al.
HEART (2002)
Autosomal dominant dilated cardiomyopathy with atrioventricular block: A lamin A/C defect-related disease
E Arbustini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
分享论文
